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012.01.0Abstract Background: Coronary artery disease (CAD) is often silent in diabetic patients, and it is
typically in advanced stages of development by the time it manifests. Various forms of stress testing
have been investigated to detect obstructive CAD in diabetes mellitus.
Objectives: To assess the diagnostic value of dobutamine stress pulsed-wave Doppler tissue imag-
ing (DTI) compared with standard wall motion analysis in detection of myocardial ischemia in dia-
betic patients with suspected CAD.
Methods: The study comprised 46 diabetic patients with suspected CAD who underwent dobuta-
mine stress echocardiography (DSE) with DTI within 4 weeks before coronary angiography (CA).
Dobutamine infusion started at 5 l/kg/min and increased up to 40 l/kg/min with additional atro-
pine during submaximal heart rate responses. In addition to wall-motion score index (WMSI) anal-
ysis, pulsed-wave DTI examination of basal and mid segments of posteroseptal, lateral, anterior,
inferior and anteroseptal walls was performed. Myocardial velocities were measured at rest in the
apical 4, 3 and 2-chamber views. The measurements were repeated at low dose (10–15 l/kg/min)
and at peak stress (40 l/kg/min). DTI measurements included peak systolic velocity (S), peak early
diastolic velocity (E) and peak late diastolic velocity (A) and the results were compared to WMSI1 Yossef Street from Talaat
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110 M.F. Elnoamanyanalysis. Patients were classiﬁed into two groups according to CA results; group (I) diabetics with
positive CA (n= 27) and group (II) diabetics with negative CA (n= 19).
Results: There was no signiﬁcant difference between the two groups in duration of diabetes, global
WMSI at rest or the D changes (stress-rest/rest) of WMSI (p> .05). Global S and global E were
signiﬁcantly lower in group I compared to group II at peak stress (11.3 ± 3.7 cm/s vs.
14.5 ± 2.2 cm/s, p< 0.01) and (11.3 ± 1.6 cm/s vs. 13.1 ± 2.1 cm/s, p< 0.01) respectively. The
cutoff points for global S and global E to detect obstructive CAD in diabetics were 11.3 cm/s
and 11.2 cm/s respectively with 75.7%, 73.4% sensitivity and 94.7%, 89.47% speciﬁcity respec-
tively. An increment (D changes) less than 0.56 in S or 0.26 in E from rest to peak stress identiﬁed
CAD with 78.8%, 89.3% sensitivity and 94.7%, 90.7% speciﬁcity respectively. The accuracy of DTI
parameters during peak stress was higher than WMSI analysis (sensitivity 74.1% vs. 59.3% and
speciﬁcity 90% vs. 79%, p< 0.01 for each). In multivariate regression analysis, only DS and DE
were independent predictors of obstructive CAD in diabetics (odd ratio: 36.16, 95% CI, 1.34–
532.01 and 63.77, 95% CI, 3.19–721.47) respectively.
Conclusion: Quantitative analysis, using DTI during DSE, adds new dimension in diagnosis of
myocardial ischemia. It is more sensitive, speciﬁc, accurate and reproducible compared with stan-
dard wall motion analysis for recognition of signiﬁcant CAD in diabetic patients.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Diabetes mellitus (DM) has recently been classiﬁed as a major
independent risk factor for development of coronary artery
disease (CAD). Epidemiologic data also indicate that, patients
with diabetes have increased cardiovascular morbidity and
mortality.1 Diabetic patients without previous myocardial
infarction have outcomes similar to those of nondiabetic
patients who had a prior infarction. These data support aggres-
sive risk factor modiﬁcation and early noninvasive identiﬁca-
tion of coronary artery disease in diabetic patients.2
Exercise electrocardiography (ECG) is the standard nonin-
vasive technique used for diagnostic and prognostic assessment
of nondiabetic patients with known or suspected CAD.3 In
diabetic patients the accuracy of exercise ECG may be lowered
as a result of several factors such as blunted response of blood
pressure and heart rate with exercise, previous silent infarc-
tions, high frequency of conduction abnormalities, left ventric-
ular hypertrophy, and reduced exercise capacity resulting from
peripheral vascular disease.3 Because of the reduced diagnostic
accuracy of exercise ECG, exercise or pharmacologic stress
with myocardial perfusion scintigraphy has been recom-
mended for diagnostic and prognostic assessment of diabetic
subjects.4
In nondiabetic subjects, stress echocardiography has been
found to enhance diagnostic and prognostic accuracy com-
pared with exercise ECG.5 The absence of ischemia on a stress
echocardiogram identiﬁes patients at low risk for future car-
diovascular events.6
Doppler tissue imaging (DTI) is a relatively recent noninva-
sive technique that records myocardial wall motion velocities
during different phases of the cardiac cycle. It evaluates global
and regional systolic and diastolic LV function.7
The combination of pulsed-wave tissue Doppler (PWDTI)
during dobutamine stress echocardiography (DSE) may pro-
vide quantitative component to myocardial function assess-
ment by measuring the contraction and relaxation velocities
of myocardial ﬁbers from the base to the apex.8–112. Aim of the work
To assess the diagnostic value of dobutamine stress pulsed-
wave DTI compared with standard wall motion analysis in
detection of myocardial ischemia in diabetic patients with sus-
pected CAD.
3. Patients and methods
3.1. Study population
The present study included 46 patients with known history of
DM. It was performed prospectively in Menoufyia University
Hospital in the period from June 2007 to February 2009.
The study was approved by the appropriate Institutional
Review Board and Institutional Ethical Committee for Human
Research. All study subjects provided written informed con-
sent regarding study procedures.
Diabetes mellitus (DM) was diagnosed according to World
Health Organization (WHO) and the American Diabetes
Association (ADA)12–14 as fasting blood glucoseP126 mg/dL
(P7.0 mmol/L) or 2 h post-load plasma glucose P200 mg/dL
(P11.1 mmol/L) or random plasma glucoseP200 mg/dL.
3.2.1. Inclusion criteria
The study included all diabetic patients who have one or more
of the following criteria:
– Known diabetic patients with 15 years duration in Type I or
10 years duration in Type II or 5 years with one or more
risk factor for CAD.15
– Resting ECG changes suggestive of ischemic heart disease.
– Positive exercise stress ECG.
– Regional wall motion abnormalities in resting echocar-
diography.3.2.2. Exclusion criteria
Patients with one or more of the following were excluded from
the study: (1) prior history of acute coronary syndrome; (2)
in diabetic patients with suspected 111valvular heart disease; (3) suspected or known aortic dissec-
tion; (4) acute pulmonary embolism; (5) acute myocarditis,
endocarditis; (6) severe systemic hypertension (more than
180/110 mmHg); (7) pregnancy; (8) hypertrophic obstructive
cardiomyopathy, restrictive cardiomyopathy; (9) ventricular
aneurysm; (10) serious arrhythmias.
3.2.3. For each patient the following was done
1. Detailed history taking.
2. Full clinical examination.
3. Standard 12-lead resting ECG.
4. Complete two-dimensional echocardiographic examination
was done using Acuson XP10 C (Acuson, Mountain view,
Calif) system equipped with DTI technology with 2.5 MHz
transducer. Examination was performed in the left lateral
decubitus position for:
A. Measurement of wall thickness, dimensions, ejection
fraction and resting wall motion abnormality.
B. Dobutamine stress echocardiography.Dobutamine stress echocardiography (DSE) requires two-
dimensional echocardiography with Doppler and an infusion
pump to deliver dobutamine. The area where DSE is per-
formed is equipped with resuscitation equipment (deﬁbrillator,
endotracheal intubation, etc.).16
3.2.4. Preparation for examination
The patients abstain from all oral intakes for at least 3 h before
the procedure. b-Blockers were withheld 48 h before testing.
The procedure as well as side effects and potential complica-
tions were explained to the patient. If baseline echocardio-
graphic images are adequate for assessment of regional wall
motion, an intravenous cannula was placed in an arm vein
for administration of medications. An infusion solution that
consists of 100 mg of dobutamine in 100 mL of 5% dextrose
was prepared, and the appropriate infusion rates in milliliters
per minute, based on the patient’s body weight, to provide dos-
ages from 5 lg/kg/min were determined. Atropine (1 mg/
10 mL) was available if needed to increase the heart rate.
The short-acting b-blocker, propranolol was available to be
administrated, if necessary, to reverse the b-adrenergic effects
of dobutamine. Nitroglycerin was available for sublingual
administration as needed. Lidocaine hydrochloride was also
available for treatment of ventricular arrhythmias.16
3.2.5. Examination procedure
Dobutamine was administrated intravenously by an infusion
pump at a starting dosage of 5 lg/kg/min. At 3-min intervals,
the dosage is increased to 10, 20, 30, and 40 lg/kg/min until a
predetermined endpoint was reached. If neither target heart
rate (85% of age-predicted maximal heart rate) nor any of
the other endpoints was reached, the infusion rate was in-
creased up to 50 lg/kg/min, or atropine was administrated
intravenously. A dose of 0.25–0.5 mg of atropine was repeated
at 1 min intervals to a maximal dose of 2 mg or until an end-
point was reached and dobutamine infusion is continued dur-
ing atropine administration.17 Throughout the dobutamine
infusion the ECG was continuously monitored and recorded
at 1 min intervals and BP is recorded every third minute.
End-points for interruption of the test were11: (1) achievement
of target heart rate; (2) maximal dose of both dobutamine and
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izontal or downsloping ST-segment depression (0.2 mV 80 ms
after the J-point compared with the baseline); (5) severe angi-
na; (6) symptomatic reduction in systolic blood pressure
>40 mmHg from baseline; (7) hypertension (blood pressure
>240/120 mmHg); (8) signiﬁcant arrhythmias or (9) any seri-
ous side effect regarded as being due to dobutamine infusion.
3.2.6. Doppler tissue imaging (DTI)
Pulsed-wave DTI examination was performed after activation
of the DTI mode of the same machine. The gain was set to an
optimal level to minimize noise. A 5 mm sample volume was
used and Doppler signals were recorded at sweep speed
100 mm/s.
The left ventricle was divided into 16 segments according to
the recommendation of American society of Echocardiogra-
phy.18 As previous studies have already indicated that, the
apex is fairly stationary and velocities obtained in that region
are negligible; so myocardial velocity was not measured in that
region.19,20 The resulting 12 LV segments were combined to re-
ﬂect the territories of the coronary arteries: midseptum, ante-
roseptal, and anterior segments were assigned to the left
anterior descending artery (LAD), basal septum and inferior
segments to the right coronary artery (RCA), and lateral and
posterior segments to the left circumﬂex (LCX).18
In each patient, echocardiographic velocities were obtained
from the apical 4, 3, 2 chambers views. These views provided
visualization of septal and lateral walls (apical 4), anterior
and inferior walls (apical 2) anteroseptal wall (apical 3). The
basal and mid segments of each wall were examined.
During systole, a major positive velocity wave (S) was re-
corded when the annulus moves toward the cardiac apex. Dur-
ing diastole, when the annulus moves toward the base away
from the apex, 2 major negative velocity waves were recorded:
one during the early phase of diastole (E) and another during
the late phase of diastole (A).21
The regional myocardial velocity waveforms measured were
systolic velocity (S) (Fig. 4), peak early diastolic ﬁlling velocity
(E) (Fig. 5) and peak late diastolic ﬁlling velocity (A) (Fig. 6).22
The isovolumic contraction time (IVCT) was calculated from
the beginning of QRS in ECG till the beginning of S (Fig. 1)
wave while the isovolumic relaxation time (IVRT) was calcu-
lated from the end of S wave till the beginning of E wave.
(Fig. 3) Time to peak S wave was measured from the beginning
of QRS in ECG till peak of S wave (Fig. 2). Time to peak E
was measured from the beginning of QRS in ECG till peak
of E wave. All measurements were obtained at baseline, low-
dose, and peak stress and were taken in a good-signal cycle
with averaging its value in three different cycles. Cardiac cycles
with extrasystolic, post extrasystolic beats, or rhythm distur-
bance were excluded.19
Wall motion score index (WMSI) also was determined at rest
and peak stress. Using a four-point scale as follows: normal (1),
hypokinetic (2), akinetic (3), dyskinetic (4). The WMSI was cal-
culated by dividing the wall motion score by the number of seg-
ments. Normal contraction results in a WMSI of 1; a higher
score index is indicative of wall motion abnormalities.18
Dobutamine stress test was considered to be positive in
cases of new or worsening wall thickening (or motion) abnor-
malities at any dobutamine (or atropine) stage in more than
one segment of the same region (Fig. 7), the condition of aki-
nesia becoming dyskinesia was not considered.11,23
Figure 1 Measurement of isovolumic contraction time at the
basal posterior septal wall in apical four chambers view at rest
(56 ms) in one patient of group II.
Figure 2 Measurement of duration of S wave (contraction time)
at the basal posterior septal wall in apical four chamber view at
rest (264 ms) in one patient of group II.
Figure 3 Measurement of isovolumic relaxation time at the
basal posterior septal wall in apical four chambers view at rest
(88 ms) in one patient of group II.
Figure 4 Measurement of peak velocity of S wave at the basal
posterior septal wall in apical four chamber view at rest (9 cm/s) in
one patient of group II.
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Selective coronary angiography was performed with the stan-
dard Judkins approach within 1 month from DSE. The
equipment used was the digital Siemens Hicor 1000 system.
All coronary angiograms were interpreted by two experiencedcardiologists who were unaware of the results of DSE. No car-
diac events occurred for any of the studied patients in the inter-
val between the time of DSE study and coronary angiography.
Figure 5 Measurement of peak velocity of E wave at the basal
posterior septal wall at rest (measured 17 cm/s) in one patient of
group II.
Figure 6 Measurement of peak velocity of A wave at the basal
posterior septal wall at rest (measured 9 cm/s) in one patient of
group II.
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diameter narrowing of one or more major epicardial arteries or
its major branches localized in the ﬁrst or middle segments of
the coronary arterial tree, observed in two orthogonal angio-
grams.11,24 For CAD location, left main stenosis was regarded
as disease of the LAD and the LCX. A ‘‘diffuse disease’’ wasdeﬁned by the presence of signiﬁcant stenosis in P2 coronary
vessels with stenosis inP2 segments of each vessel. The results
of coronary angiography were compared to those of dobuta-
mine stress with standard wall motion analysis and DSE with
DTI.
According to the results of the coronary angiography, the
patients were divided into two groups: group (I); DM with
CAD comprised 27 patients with signiﬁcant (>50%) coronary
stenosis and group (II); DM without CAD comprised 19 pa-
tients with normal ﬁndings or non-signiﬁcant lesions in coro-
nary arteries.
4. Statistical analysis
Data were analyzed by SPSS statistical package version 16.0
(SPSS INC, Chicago, IL, USA). Quantitative data expressed
as mean and standard deviation (SD). Student-t test was used
for comparison of the means of two groups of quantitative
variables. Qualitative data expressed as number and percent-
age and analyzed by Chi-square (v2) or Fisher exact test when
appropriate.
Diagnostic performance of DSE tested by measuring sensi-
tivity, speciﬁcity, positive predicative value (PPV), negative
predicative value (NPV) and accuracy.
The diagnostic performance of global S, Delta (D) S, global
E, Delta (D) E or the ability to discriminate diseased cases
from normal cases is evaluated using receiver operating char-
acteristic (ROC) curve analysis to determine the appropriate
cut-off points.
Multivariate logistic regression was used to assess indepen-
dent predicators of positive coronary angiography (ischemia)
among patients using clinical, laboratory and echocardiographic
variables. Level of signiﬁcance was set as p value <0.05.25
5. Results
From 56 diabetic patients recruited for the study, 46 patients
were included for the study analysis (10 patients did not under-
go coronary angiography). According to coronary angio-
graphic results diabetic patients were classiﬁed into two
groups; group I diabetic patients with positive coronary angi-
ography included 27 patients (16 males and 11 females with
mean age 64.52 ± 6.6 years) and group II diabetic patients
with negative coronary angiography included 19 patients (11
males and 8 females with mean age 59.11 ± 6.5 years).
By comparing both groups, no signiﬁcant difference was
found between group I and group II as regards the age, gender
difference, diabetes duration, prevalence of hypertension, sys-
tolic or diastolic blood pressure levels, resting heart rate, total
cholesterol or triglycerides levels (p> 0.05). The percentage of
smokers was signiﬁcantly higher in group I than group II
(p< 0.05) (Table 1).
Concerning conventional echocardiographic parameters,
no signiﬁcant difference was found between the group I and
group II except in WMSI with stress which was signiﬁcantly
higher in group I in comparison to group II (p< 0.05) (Table 1).
There was a signiﬁcant difference between group I and
group II as regards response of systolic (S) velocity and early
diastolic (E) velocity measured during dobutamine DTI from
rest to peak stress (p< 0.001 for each). On the contrary there
was no signiﬁcant difference between the two groups regarding
the response of late diastolic (A) velocity (p> 0.05) (Table 2).
Figure 7 Example of biphasic response of S wave velocity indicating ischemia in one patient of group (I). The peak velocity of S wave
measured at mid posterior septal wall at rest, panel A (7 cm/s), low dose, panel B (15 cm/s) and peak stress, panel C (12 cm/s).
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at different LV walls demonstrated that, isovolumic contrac-
tion time (IVCT), contraction time (CT), time to peak S and
time to peak E were signiﬁcantly prolonged in all walls at peak
stress in group I compared to group II, while S and E velocitieswere signiﬁcantly lower in group I when compared to the val-
ues of the corresponding walls in group II. The isovolumic
relaxation time measured at peak stress was found to be more
prolonged in all LV walls in group I compared to group II,
however the difference did not reach the statistically signiﬁcant
Table 1 Baseline demographic, clinical, laboratory & echocardiographic data of the studied groups.
Group I Positive CA
(n= 27)
Group II Negative CA
(n= 19)
T test p value
Age (mean ± SD) 64.52 ± 6.6 59.11 ± 6.5 1.29 >0.05
Gender
Male 16 (59.3%) 11 (57.9%) v2 = 2.24 >0.05
Female 11 (40.7%) 8 (42.11%)
BMI (kg/m2) 30.24 ± 5.5 31.5 ± 5.8 0.71 >0.05
Hypertension (%) 19 (70.4%) 15 (78.9) v2 = 0.42 >0.05
DM duration (years) 10.82 ± 5.82 9.28 ± 5.14 2.11 >0.05
Smoking (%) 11 (40.7%) 4 (21.1%) v2 = 1.96 <0.05
SBP (mmHg) 135.19 ± 14.24 135.26 ± 15.76 0.01 >0.05
DBP (mmHg) 87.04 ± 9.12 84.74 ± 7.72 0.89 >0.05
HR (b/min) 75.70 ± 7.28 79.84 ± 7.41 1.88 >0.05
Total cholesterol bn(mg/dL) 232.41 ± 40.36 224.32 ± 46.20 1.48 >0.05
Triglycerides (mg/dL) 160.93 ± 37.30 155.53 ± 33.19 0.50 >.0.05
IVS (mm) 10.41 ± 1.9 11.21 ± 2.3 1.28 >0.05
LVEDD n(mm) 48.26 ± 4.9 48.21 ± 3.9 0.03 >0.05
LVESD n(mm) 10.74 ± 3.8 11.89 ± 5.2 0.86 >0.05
LVPW (mm) 29.78 ± 6.0 28.21 ± 5.6 0.89 >0.05
FS% 35.59 ± 4.3 37.05 ± 5.8 0.98 >0.05
EF% 65.93 ± 5.5 67.68 ± 5.8 1.04 >0.05
WMA (%) 2 (7.4%) 1 (5.3%) Fisher exact >0.05
WMSI
At rest 1.05 ± 0.18 1.05 ± 0.23 0.01 >0.05
With stress 1.52 ± 0.49 1.18 ± 0.38 2.59 <0.05
BMI, body mass index; DM, diabetes mellitus; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; IVS, Interven-
tricular septum; LVEDD, left ventricular end diastolic diameter; LVESD, left ventricular end systolic diameter; LVPW, left ventricular posterior
wall; FS, fractional shortening; EF%, ejection fraction; WMA, wall motion abnormality; WMSI, wall motion score index.
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difference was detected between the two groups at peak stress
(Table 3).
Changes in global myocardial systolic and early diastolic
velocities measured from rest to peak stress and (D) change
in these velocities (measured as the difference between the peak
stress-rest values) were all signiﬁcantly lower in group (I) when
compared group (II) (Table 4).
Using ROC curve, the cutoff points with best validity crite-
ria (sensitivity and speciﬁcity) were determined for each DTI
parameter for prediction of obstructive CAD in diabetic pa-
tients. The cutoff points for global S and global E were
11.3 cm/s and 11.2 cm/s with 75.7%, 73.4% sensitivity and
94.7%, 89.47% speciﬁcity respectively. For DS and DE the cut-
off points were 0.56, 0.26 with 78.8%, 89.3% sensitivity and
94.7%, 90.7% speciﬁcity respectively (Table 5).
Comparing the validity criteria of WMSI and DTI dobuta-
mine stress in detection of CAD in diabetic patients, the latter
was found to be more sensitive (74.1% vs. 59.3%) and more
speciﬁc (90% vs. 79%).
Moreover, dobutamine stress DTI had higher positive pre-
dictive value (91% vs. 80%), higher negative predictive value
(71% vs. 57.7%) and better accuracy (80.4% vs. 67.4%) in
detection of CAD in the studied patients (Table 6).
In multivariate logistic regression analysis of all clinical,
laboratory and echocardiographic variables for prediction of
obstructive CAD in patients with DM, only DE 6 0.26 was
the most signiﬁcant powerful independent predictor followed
by DS 6 0.56, (p< 0.01, <0.05 respectively) (Table 7).In analyses testing the reproducibility, the interobserver
and intraobserver variabilities were compared in 40 consecu-
tive measurements and were 2.1% and 3.3%, respectively,
for the measurement of DS and for measurement of DE were
3.9% and 3.7%, respectively. Accordingly, each parameter
has good limits of interobserver and intraobserver variabilities
accounting for good reproducibility. Validation had been con-
ﬁrmed in previous studies.11,26
6. Discussion
Coronary artery disease (CAD) is the leading cause of death in
patients with DM. Patients often present with advanced and
asymptomatic disease.27 Although mortality from cardiovas-
cular disease has declined in the general population, the decline
is much less in diabetic men and in diabetic women there is
actually an increase in cardiovascular mortality.28 These data
emphasize the importance of accurate risk stratiﬁcation of dia-
betic patients to identify diabetic patients with subclinical dis-
ease at a high risk of future cardiac events.
In the present study, diabetic patients were investigated for
CAD using dobutamine stress DTI. To the best of our knowl-
edge this is the ﬁrst study to assess the diagnostic accuracy of
dobutamine stress DTI in diabetic patients with suspected
CAD.
In our study, the validity of DTI parameters during peak
stress was higher than WMSI analysis (sensitivity 74.1% vs.
59.3% and speciﬁcity 90% vs. 79%, p< 0.01 for each). More-
over, dobutamine stress DTI had higher positive predictive
Table 2 Myocardial velocities response to dobutamine stress in studied groups.
Peak systolic velocity (S) Group I
Positive CA (n= 27)
Group II
Negative CA (n= 19)
v2 p
No % No %
Decreased 10 37.04 0 0.0 9.05 <0.001
Biphasic 10 37.04 3 15.8
Increased 7 25.9 16 84.2
Early diastolic velocity (E)
Decreased 18 66.67 4 21.1 10.98 <0.001
Biphasic 2 7.41 0 0.0
Increased 7 25.9 15 78.9
Atrial diastolic velocity (A)
Decreased 3 11.1 2 10.5 0.73 >0.05
No change 1 3.7 0 0.0
Increased 23 85.2 17 89.5
116 M.F. Elnoamanyvalues (91% vs. 80%), higher negative predictive values (71%
vs. 57.7%) and better accuracy (80.4% vs. 67.4%) in detection
of CAD in diabetic patients.
Doppler tissue imaging (DTI) provides a quantitative analy-
sis of regional myocardial function through its excellent ability
to quantify regional myocardial contraction and relaxation
velocities and has good temporal resolution allowing accurate
estimation of the very short time intervals during the cardiac
cycle.29 In our study, addition of DTI toDSE has the advantage
of quantitative analysis that enables to detect the appropriate
cut off values during peak stress that differentiate between
patients with obstructive (group I) and normal or nonobstruc-
tive (group II) CAD (global S 6 11.3 cm/s, global E 6
11.2 cm/s, DS 6 0.56 and DE 6 0.26). Furthermore, in multi-
variate logistic regression analysis of predictors of obstructive
CAD in patients with DM, only DE 6 0.26 was the most signif-
icant powerful independent predictor followed by DS 6 0.56
(p< 0.01, <0.05 respectively).
6.1. Conventional DSE and WMSI in diagnosis of CAD among
diabetics
The prognostic value of DSE in diabetic patients with known
or suspected CAD has been previously demonstrated.30,31
However, given their high-risk status for the development of
cardiovascular diseases, diabetic patients present with a sub-
stantially increased pretest likelihood of adverse outcome.
Thus, to verify whether the test conveys similar prognostic
information in diabetic and nondiabetic patients is of primary
clinical relevance.32
In our study, despite WMSI measured during peak dose
DSE was higher in diabetic patients with obstructive CAD,
it has lower sensitivity, speciﬁcity and predictive power com-
pared to dobutamine stress DTI.
In agreement with our ﬁndings, Masoor et al.28 postulated
that, diabetic patients with negative DSE were twice as likely
to have cardiac events and four times more likely to have non-
fatal infarctions compared with nondiabetic subjects. They
suggested that, the absence of ischemia is a less reliable predic-
tor of event-free survival in diabetic patients. The cause of the
reduced predictive value of a negative DSE in diabetic patients
is unknown. One possibility is that, diabetic patients are more
likely to have diffuse distal vessel disease. In this setting,regional wall motion abnormalities may be more difﬁcult to
detect with stress because of global rather than regional reduc-
tion of perfusion reserve.28
Furthermore, Anne et al.33 reported that, diabetic patients
with normal DSE appear to have a greater risk for subsequent
cardiovascular events than nondiabetic patients, particularly
beyond 2 years. Similarly, Kamalesh et al.34 found increased
incidence of cardiac events despite negative DSE in DM cohort
(6% vs. 2.9% yearly).
6.2. Additional role of DTI to DSE in diagnosis of CAD among
diabetics
In our study, application of DTI during DSE makes the pro-
cedure easy, quantitative, with higher sensitivity, speciﬁcity,
accuracy and reproducibility than standard WMSI analysis.
This superiority helps to diagnose obstructive CAD in diabet-
ics more accurately without additional risk or cost.
In agreement with our ﬁndings, Pellikka26 demonstrated
that, DTI is promising technique to reduce intraobserver and
interobserver variabilities for the interpretation of stress echo-
cardiograms. Moreover, this technique offers the potential to
quantify the extent of ischemia. In addition to assessment of
indices of contractile function, distinct patterns of diastolic
function can be depicted during ischemia with an accuracy
which probably cannot be appreciated by the naked eye.26
Fraser et al.35 in the MYDISE (Myocardial Doppler in
Stress Echocardiography) study, used myocardial Doppler
velocities during DSE for diagnosis of CAD comparing its re-
sults with coronary angiography. They demonstrated that,
CAD can be diagnosed accurately and objectively, from off-
line measurements of myocardial velocities recorded non-inva-
sively by DTI during DSE. Furthermore the accuracy of DTI
in diagnosis of CAD is much more than conventional analysis
of wall motion abnormalities.35
Wall motion analysis of the inferobasal segment of the left
ventricle is a common problem during DSE and may be a
cause for unnecessary coronary angiography. Even resting
imaging of the inferobasal segment often demonstrates abnor-
mal motion as a result of close proximity of the mitral valve
and atrioventricular groove. During DSE, this impairment
may become more prominent and can be interpreted incor-
rectly as ischemia.36 Leitman et al.36 investigated changes of
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Diagnostic value of dobutamine stress Doppler tissue imaging in diabetic patients with suspected 117the inferobasal segment during DSE with DTI in 50 patients
with more than 70% stenosis of RCA and compared the re-
sults with coronary angiography. They reported that, conven-
tional stress echocardiography was falsely positive in 10.3%
and falsely negative in 27.3%. When DTI was combined with
conventional stress echocardiography, it enhances the diagno-
sis of inferior ischemia during DSE and it improves sensitivity
and speciﬁcity up to 81.8% and 97.4% respectively and
accordingly can be added to conventional imaging protocol
in those patients.36
6.2.1. Changes in myocardial velocities and time intervals during
dobutamine stress – DTI
In our study, comparing measurements of dobutamine stress
DTI parameters at different walls in the two studied groups
with results of coronary angiography revealed that, peak sys-
tolic velocity (S) and early diastolic velocity (E) become signif-
icantly lower in all walls at peak stress in group I compared to
group II. Regarding late diastolic velocity (A), there was no
signiﬁcant difference between the two groups.
These results are in agreement with data reported by Von
Bibra et al.37 using pulsed Doppler myocardial mapping of
12 left ventricular segments during DSE, and reported, a
stress-induced reduction of peak lengthening of early diastolic
velocity which was accurate and superior to peak systolic
tissue Doppler recordings for detecting coronary artery
stenosis.37
Several investigators had shown Doppler myocardial veloc-
ity imaging to be a sensitive alternative to the conventional
echocardiographic and scintigraphic imaging techniques to
evaluate stress tests. The peak velocity response for both sys-
tole and diastole has been shown to be signiﬁcantly lower dur-
ing dobutamine stress in mal-perfused myocardial regions
compared to normal.37,38
Jelena et al.39 examined 60 patients without previous myo-
cardial infarction who underwent DSE. Peak systolic, early
and late diastolic velocities were measured at rest and during
stress and they found that, there was no signiﬁcant difference
between ischemic and non-ischemic groups in systolic and both
diastolic velocities at rest. However, pronounced differences
developed during stress in all segments, peak systolic velocity
in the ischemic group during stress was lower than in the
non-ischemic group (p< 0.05). Furthermore clear difference
between the two groups was found in the magnitude of early
diastolic ﬁlling wave (E0) during stress (p< 0.04).39
Concordant to our ﬁndings, Ofelia et al.40 studied 63
patients for CAD by measuring regional diastolic velocities
using DTI during DSE and comparing it to results of coronary
angiography they concluded that, E velocity in patients with
CAD showed a lower value at peak stress compared with con-
trol (p< 0.001). On the other hand, the A velocity in both
groups did not show any signiﬁcant difference at baseline
and peak stress.40 Similarly, Yamada et al.38 reported blunting
of the E velocity from baseline to peak stress in ischemic com-
pared with nonischemic segments.
In our study, the isovolumic contraction time, contraction
time, time to peak S and time to peak E showed signiﬁcant
prolongation during peak stress in group I compared with
group II. These parameters represent more deterioration of
myocardial function (both systolic and diastolic) during peak
stress. Although the isovolumic relaxation time measured at
peak stress was found to be more prolonged in group I
Table 4 Changes of global myocardial systolic velocity (S), early diastolic velocity (E) and D change from rest to stress in studied
patients.
Group I (n= 27) Group II (n= 19) T test p value
Global S (cm/s) 11.30 ± 3.66 14.48 ± 2.16 3.69 <0.01
Global E (cm/s) 11.27 ± 1.63 13.12 ± 2.10 3.16 <0.01
DS 0.50 ± 0.51 0.93 ± 0.30 3.56 <0.01
DE 0.21 ± 0.16 0.42 ± 0.16 4.40 <0.001
S, systolic velocity; E, early diastolic velocity; D, Delta.
Table 5 Cutoff points of Doppler tissue parameters in
diagnosis of CAD in diabetic patients.
Sens. (95% CI) Spec. (95% CI)
Global S 6 11.3 (cm/s) 75.7 (55.4–94.3) 94.7 (73.9–99.1)
Global E 6 11.2 (cm/s) 73.4 (54.6–93.1) 89.47 (66.8–98.4)
DS 6 0.56 78.8 (54.3–95.7) 94.7 (73.9–99.1)
DE 6 0.26 89.3 (68.7–105.9) 90.7 (71.4–101.4)
S, systolic velocity; E, early diastolic velocity; D, Delta; CI, conﬁ-
dence interval.
118 M.F. Elnoamanycompared to group II, the difference did not reach the statisti-
cally signiﬁcant level.
Similar to our data, Jun et al.41 reported prolongation of
isometric contraction time and ejection time in ischemic pa-
tients using pulsed-wave DTI with DSE.Table 6 Criteria of the validity of DSE with Doppler tissue imagin
Diabetes mellitus.
Doppler tissue imaging Coronary angiography Se
Group I (n= 27) Group II (n= 19)
Positive 20 2 74
Negative 7 17
WMSI
59Positive 16 4
Negative 11 15
PPV, positive predictive value; NPV, negative predictive value; WMSI, w
Table 7 Multivariate logistic regression analysis of predictors of ob
Variables B SE Wald v2
Age 0.22 0.12 3.11
Male sex 1.29 1.75 0.54
Hypertension 0.29 1.33 0.04
Smoking 0.52 1.85 0.07
DM (year) 0.13 0.11 1.53
TC> 200 mg/dl 1.608 1.23 1.69
WMSI > 1 0.39 1.32 0.08
DS 6 0.56 3.58 1.68 4.55
DE 6 0.26 4.15 1.52 7.39
Constant 16.56 8.56 3.84
DM, diabetes mellitus; TC, total cholesterol; WMSI, wall motion score
conﬁdence interval; OR, odds ratio; SE, standard error.Kugacka et al.42 reported that, the value of isovolumic
relaxation time corrected for heart rate (IVRTc) = 80 ms at
peak dobutamine infusion is able to discriminate patients with
residual ischemia from those without with a sensitivity of 80%
and a speciﬁcity of 70%.
However, these time intervals are not so reliable due to dif-
ferent variabilities of its measurement especially at a higher
heart rate when both systolic and diastolic time intervals are
getting shorter.
6.3. Study limitations
The limited number of patients could limit the strength of the
ﬁndings obtained from the study; future large scale studies are
recommended for more validation of the results. The difﬁculty
of quantifying the apical segments using myocardial Doppler
velocities is because of the relatively immobile nature of theg versus standard wall motion analysis in diagnosis of CAD in
nsitivity % Speciﬁcity % PPV % NPV % Accuracy %
.1 90 91 71 80.4
.3 79 80 57.7 67.4
all motion score index.
structive CAD in diabetes mellitus.
p OR 95.0% CI for OR
Lower Upper
>0.05 1.25 0.97 1.61
>0.05 3.65 0.11 113.36
>0.05 1.34 0.09 18.46
>0.05 0.59 0.01 22.43
>0.05 1.14 0.92 1.42
>0.05 4.99 0.44 56.20
>0.05 0.67 0.05 9.00
<0.05 36.16 1.34 532.01
<0.05 63.77 3.19 721.47
<0.05
index; S, systolic velocity; E, early diastolic velocity; D, delta; CI,
Diagnostic value of dobutamine stress Doppler tissue imaging in diabetic patients with suspected 119apex, and therefore an inherent limitation of the assessment of
base–apex axis function. However, despite the inability of the
test to identify apical wall motion abnormalities, this did not
emerge as a major impediment to overall sensitivity in this
study. When using the pulsed wave-DTI technique, the proce-
dure is relatively time consuming because of the large number
of measurements needed to be recorded from the standard
myocardial segments. Doppler tissue imaging measurements
are affected by cardiac translational movements, tethering ef-
fect and angulations, however these could be minimized by
using more relatively recent DTI techniques and choosing
myocardial regions of interest within 15–20 of the axis of
Doppler interrogation.
7. Conclusion
Doppler tissue imaging is a promising technique allowing
accurate quantiﬁcation of ischemia induced regional diastolic
and systolic dysfunction and when used during dobutamine
stress echocardiography, it adds new dimension to the diagno-
sis of myocardial ischemia in diabetic patients. It is more sen-
sitive, speciﬁc, accurate and reproducible than standard wall
motion analysis for recognition of signiﬁcant CAD in such cat-
egory of patients.
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